CORDENPHARMA CHENÔVE (FR)
Core Capabilities
- >> NCE cGMP custom synthesis from kilolab to multi tonne scale
- >> Multi-step API process development, manufacturing and analytical development
- >> Continuous Manufacturing utilizing flow chemistry
- >> Industrialization from feasibility to commercial scale
- >> Regulatory filing in the US, EU and Japan
- >> Pharmaceutical establishment in production of bulk pre-mixed drug products
COMPLIANCE
- >> Inspected by French National Agency for Medicines and Health Products Safety (ANSM)
- >> Registered in the EUDRAGMDP database according to EU Directive 62/2011
- >> Relevant GMP Certificates are available on EUDRAGMDP database
- >> Inspected by the US-FDA since 1995 (FEI 3002808295) and accredited in Japan since 2010 (AG21000001)
- >> The QMS assures compliance to cGMP – as per EU GMP, Part II and ICH Q7
- >> Corden Pharma Chenôve Inspections
CordenPharma 15 Year Anniversary
Related Products & Platforms
Related Drug Products
Technology Platforms
Facility Legacy
CordenPharma Chenôve (formerly Synkem) is a cGMP manufacturer of APIs and advanced pharmaceutical intermediates specializing in synthetic route design and development.
As a former facility of Solvay Pharmaceuticals, CordenPharma Chenôve brings over 25 years of experience and expertise in pharmaceutical chemistry, technology, project management and registration processes to CordenPharma’s full-service CDMO platform.
HISTORY
- >> 1960 MSD facility
- >> 1985 Facility purchased by Fournier Laboratories
- >> 1995 First FDA inspection
- >> 2005 Fournier Laboratories taken over by Solvay Pharmaceuticals
- >> 2008 Synkem acquired by ICIG
- >> 2016 Synkem name changed to Corden Pharma Chenôve SAS
- >> 2022 Astorg acquires CordenPharma from ICIG
Managing Director
Dr. James Leresche
Corden Pharma Chenôve SAS
47, rue de Longvic
B.P. 50
21301 Chenôve Cedex
France
Phone: +33 380 447 272
Fax: +33 380 447 270